PANDAR and gastric cancer: siRNA-mediated PANDAR silencing was combined with miR-637 inhibitor treatment to evaluate their synergistic impact on gastric cancer cell proliferation miR-637 could reverse the inhibitory effect of PANDAR on GC cells proliferation (P < 0.0001, Fig. 4B), suggesting its potential involvement in the regulatory mechanism of PANDAR.